Published in Women's Health Weekly, May 6th, 2004
"This year's pipeline presentations at the AACR annual meeting are especially exciting for us because many of the research programs being discussed are nearing the clinical phase of development," said Daniel S. Lynch, CEO of ImClone Systems. "Utilizing these data and other preclinical research, ImClone Systems is working toward the filing of investigational new drug applications over the next 18 months to advance several programs into clinical trials, including...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.